HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

3- (3,4- dichlorobenzyl)- 5- (3,4,5- trihydroxybenzylidene)thiazolidine- 2,4- dione

a PAI-1 inhibitor; structure in first source

Also Known As:

IMD 1622; IMD-1622; IMD1622

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Sulfur Compounds: 278
  - Thiazoles: 392
    - Thiazolidinediones: 2250
      - 3-(3,4-dichlorobenzyl)-5-(3,4,5-trihydroxybenzylidene)thiazolidine-2,4-dione: 1
Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Azoles: 2138
    - Thiazoles: 392
      - Thiazolidinediones: 2250
        3-(3,4-dichlorobenzyl)-5-(3,4,5-trihydroxybenzylidene)thiazolidine-2,4-dione: 1

Experts

1.	Isobe, Mitsuaki: 1 article (07/2008)
2.	Itai, Akiko: 1 article (07/2008)
3.	Muto, Susumu: 1 article (07/2008)
4.	Ogawa, Masahito: 1 article (07/2008)
5.	Suzuki, Jun-ichi: 1 article (07/2008)
6.	Yamaguchi, Yoichi: 1 article (07/2008)

Related Diseases

1.	Thrombosis (Thrombus) 07/01/2008 - "While the non-treated shunt model showed massive thrombus formation, IMD-1622 administration suppressed this. "